Related by context. Frequent words. (Click for all words.) 79 Single Dose 78 Elderly Patients 78 Well Tolerated 77 Drug Candidate 77 Completes Enrollment 77 Advanced Prostate Cancer 76 Phase III Clinical Trial 75 Clinical Trial Results 75 Patients Treated 75 Heart Failure Patients 75 Monotherapy 74 Presents Positive 74 II Clinical Trial 74 Pediatric Patients 74 Phase III Trial 74 Preclinical Data 74 Patients Undergoing 74 Significantly Reduces 74 Pivotal Phase III 73 Chronic Hepatitis B 73 Reduces Risk 73 Chronic Hepatitis C 73 Metastatic Colorectal Cancer 73 Postmenopausal Women 73 Metastatic Melanoma 73 Increases Risk 73 Generic Version 73 FDA Accepts 72 Initiates Phase 72 Patient Enrollment 72 Tolerability 72 Initiate Phase 72 Overactive Bladder 72 FDA Clears 72 Recombinant Human 72 Benign Prostatic Hyperplasia 72 Pivotal Study 72 Prostate Cancer Patients 72 Newly Diagnosed 72 J Am Coll 72 Generalized Anxiety Disorder 71 FDA Approves 71 Study Demonstrates 71 Pivotal Phase 71 Extended Release 71 Meta Analysis 71 Anti Inflammatory 71 Diabetic Patients 71 Pulmonary Arterial Hypertension 71 Chronic Heart Failure 71 Combination Therapy 71 J Am Acad 71 Monoclonal Antibody 71 Coadministration 70 CHEAP ONLINE PHARMACY LOW 70 Pivotal Trial 70 Venous Thromboembolism 70 Cardiovascular Events 70 Urinary Incontinence 70 Antipsychotic 69 Cognitive Decline 69 Increased Risk 69 Capecitabine 69 Positive Opinion 69 Atopic Dermatitis 69 Low Dose 69 Tumor Growth 69 Solid Tumors 69 Relapsed 69 refractory chronic lymphocytic 69 Urinary Tract Infections 69 Free Full Text 69 Helps Prevent 69 Inhibits 69 Major Depressive Disorder 69 Randomized Controlled Trial 69 Lung Cancer Patients 69 Cholesterol Drug 68 FDA Warns 68 Etanercept 68 Receives FDA Clearance 68 Drug Resistant 68 Breast Cancer Patients 68 Post Operative 68 Blood Thinner 68 Breast Cancer Treatment 68 CHEAP ONLINE PHARMACY BEST 68 Develop Novel 68 Announces FDA Clearance 68 Shows Promise 68 Blood Clots 68 Hormone Therapy 68 Aliskiren 68 Allergic Rhinitis 68 REVLIMID R 67 Am J Clin 67 Eculizumab 67 Natalizumab 67 Golimumab 67 Reduce Risk 67 Systematic Review